Sigrima 420 Mg Injection
In stock
Description
Sigrima 420 mg Injection (pertuzumab) is a targeted therapy used primarily to treat HER2-positive breast cancer, including early-stage and metastatic forms. It works by binding to HER2 receptors, inhibiting tumor growth, and inducing cell death (apoptosis), often used in combination with trastuzumab and chemotherapy to improve survival.
Specifications
| Strength | 420 mg |
|---|---|
| Storage | 2 - 8°C |
| Uses | Breast cancer |
| Pack | Vial |
| Main Ingredients | Pertuzumab |
